Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E G Routledge

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Gene Therapy|September 7, 1999
Antigen-specific membrane fusion mediated by the haemagglutinin protein of influenza A virus: separation of attachment and fusion functions on different moleculesS M Patterson, R Swainsbury, E G Routledge
The Journal of General Virology|April 11, 2006
Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse-human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoproteinC Mekseepralard, G L Toms, E G Routledge
The Journal of General Virology|August 1, 1989
Monoclonal antibodies to feline calicivirusM J Carter, E G Routledge, G L Toms
Journal of Medical Virology|March 1, 1985
The development of monoclonal antibodies to respiratory syncytial virus and their use in diagnosis by indirect immunofluorescenceE G Routledge, J McQuillin, A C Samson, et al.
European Journal of Immunology|November 1, 1991
A humanized monovalent CD3 antibody which can activate homologous complementE G Routledge, I Lloyd, S D Gorman, et al.
Therapeutic Immunology|October 1, 1994
Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysisJ Greenwood, S D Gorman, E G Routledge, et al.
Transplantation|October 27, 1995
The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibodyE G Routledge, M E Falconer, H Pope, et al.
The Journal of General Virology|September 1, 1986
Respiratory syncytial virus glycoprotein expression in human and simian cell linesE G Routledge, M M Willcocks, A C Samson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Reshaping a therapeutic CD4 antibodyS D Gorman, M R Clark, E G Routledge, et al.
The Journal of General Virology|July 1, 1986
A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion proteinA C Samson, M M Willcocks, E G Routledge, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Gene Therapy|September 7, 1999
Antigen-specific membrane fusion mediated by the haemagglutinin protein of influenza A virus: separation of attachment and fusion functions on different moleculesS M Patterson, R Swainsbury, E G Routledge
The Journal of General Virology|April 11, 2006
Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse-human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoproteinC Mekseepralard, G L Toms, E G Routledge
The Journal of General Virology|August 1, 1989
Monoclonal antibodies to feline calicivirusM J Carter, E G Routledge, G L Toms
Journal of Medical Virology|March 1, 1985
The development of monoclonal antibodies to respiratory syncytial virus and their use in diagnosis by indirect immunofluorescenceE G Routledge, J McQuillin, A C Samson, et al.
European Journal of Immunology|November 1, 1991
A humanized monovalent CD3 antibody which can activate homologous complementE G Routledge, I Lloyd, S D Gorman, et al.
Therapeutic Immunology|October 1, 1994
Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysisJ Greenwood, S D Gorman, E G Routledge, et al.
Transplantation|October 27, 1995
The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibodyE G Routledge, M E Falconer, H Pope, et al.
The Journal of General Virology|September 1, 1986
Respiratory syncytial virus glycoprotein expression in human and simian cell linesE G Routledge, M M Willcocks, A C Samson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Reshaping a therapeutic CD4 antibodyS D Gorman, M R Clark, E G Routledge, et al.
The Journal of General Virology|July 1, 1986
A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion proteinA C Samson, M M Willcocks, E G Routledge, et al.
Pageof 2